Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03894423 · ClinicalTrials.gov registry record

Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery

A clinical trial of CAD and Coronary Artery Bypass, sponsored by Stanford University.

Recruiting
Registry status
200
Enrollment target
3
Study locations

NCT03894423: Recruiting study of CAD and Coronary Artery Bypass, sponsored by Stanford University.

NCT03894423 is a study of CAD and Coronary Artery Bypass that is actively recruiting participants, run by Stanford University. The registered enrollment target is 200 participants, below the 1,995-participant average among 4 other CAD trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03894423, a study of CAD and Coronary Artery Bypass, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
200 participants
Enrollment target
3
Study locations

Study Summary

Apply CT angiography, CT perfusion imaging and advanced image processing techniques to improve revascularization decision-making and surgical strategies in patients undergoing coronary artery bypass graft surgery.

Primary Outcome

Myocardial blood flow will be measured by dynamic stress CT perfusion imaging before and 2 months after CABG. The primary endpoint is the difference MBF values between both examinations, per coronary distribution.

Study Locations (3)

California

  • Palo Alto Veterans Affaird Healthcare System - Palo Alto
  • Stanford University - Palo Alto
  • University of California San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-05-01
Est. Completion 2028-01
Stanford University

1,744 total trials

What NCT03894423 shows while recruiting

NCT03894423 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,995-participant average among 4 other CAD trials with a reported enrollment target (90% lower).

The record links to 4 conditions, with CAD appearing as the primary indexed condition, and to 0 interventions.

NCT03894423 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03894423 about?

NCT03894423 is a clinical study titled "Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery". Apply CT angiography, CT perfusion imaging and advanced image processing techniques to improve revascularization decision-making and surgical strategies in patients undergoing coronary artery bypass graft surgery.

What is the current status of trial NCT03894423?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2019-05-01. Estimated completion is 2028-01.

What conditions does trial NCT03894423 study?

This clinical trial studies the following conditions: CAD, Coronary Artery Bypass, Computed Tomography, Atheroscleroses, Coronary.

Who is sponsoring clinical trial NCT03894423?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03894423 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for CAD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03894423, the US trial registry maintained by the National Library of Medicine. NCT03894423 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.